UK-based Rem3dy Health raises €16 million to support expansion into key markets

Birmingham-based Rem3dy Health, a HealthTech scale-up and parent company of personalised nutrition brand, Nourished, today announced the completion of a €16 million (£14 million) fundraise, supporting growth and expansion into key international markets.

The round was led by a group of global strategic investors, including Suntory, Estrella Galicia, Apollo Hospitals, and UPSA, while investment from Birmingham’s Future Planet Capital Regional further signals the company’s regional roots.

“Securing this funding marks a major milestone for us. Following a year of significant transformation and against one of the toughest fundraising environments in recent years, we are now in a strong position to scale globally,” says Melissa Snover, Founder and CEO of Rem3dy Health.

The company’s aim is to use these funds to enter key international markets including the US, MENA region and India, whilst also enabling the company to move into personalised health solutions for pets.

This fundraise forms part of the €148.2 million of disclosed funding which has been invested in HealthTech, preventive health, digital care and patient-facing care in 2026 according to our coverage. The UK is particularly relevant in these areas with London-based startups Semble, JAAQ and Calibre closing significant rounds in recent months.

While Rem3dy Health’s focus on AI-driven personalised nutrition and advanced manufacturing is more consumer-wellness oriented than many of these healthcare-delivery platforms, the round fits within a broader 2026 context in which investors are backing companies that use data, automation and personalisation to support more scalable health-related services.

“We are delighted to see Rem3dy Health continue to attract significant backing to fuel their already impressive growth. When we first invested in Rem3dy, it was clear they were developing a truly disruptive brand and technology capable of revolutionising the global wellness industry,” added Rupert Lyle, Investment Director at Future Planet Capital Regional and Fund Principal of West Midlands Co-Investment Fund (WMCO).

Founded in 2019, Rem3dy Health uses AI-driven personalised nutrition and advanced manufacturing, combining data science, 3D printing and automation to deliver tailored health solutions at scale.

The company says the investment highlights a broader strategic shift, with global consumer and healthcare players increasingly backing next-generation health technology businesses.

Estrella Galicia’s participation, for example, is said to signal expansion beyond traditional categories, while Apollo Hospitals is said to bring expertise from one of the world’s largest integrated healthcare providers.

The post UK-based Rem3dy Health raises €16 million to support expansion into key markets appeared first on EU-Startups.